Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromodomain Y-linked 3 pseudogene (CDY3P) is a pseudogene located on the Y chromosome in humans. Unlike functional genes, it does not encode a functional protein. The "chromodomain" nomenclature refers to a protein domain originally associated with chromatin organization and gene regulation, present in ancestral protein-coding genes on the Y chromosome, such as CDY1 and CDY2. However, as a pseudogene, CDY3P contains sequence similarities to these genes but has lost functional protein-coding ability due to disabling mutations[4][8]. Pseudogenes like CDY3P may retain partial transcriptional activity and, in broader pseudogene biology, can occasionally yield regulatory non-coding RNAs. These non-coding transcripts may act as miRNA decoys, compete with their parent genes for regulatory molecules, or produce siRNAs that can modulate the expression of related genes, although these roles are generally uncharacterized and unproven for CDY3P specifically[1][2][5]. There is no evidence that CDY3P acts as a receptor, enzyme, transporter, or other tractable therapeutic target, nor is there evidence it serves as a disease biomarker or drug target. Summary of Interpretation: CDY3P is a nonfunctional gene relic found on the human Y chromosome. It is not considered a druggable or therapeutic target, nor does it have direct disease associations or interactions with therapeutics. Its regulatory or biological effects, if any, are not established or characterized in the literature[1][4][8]. If information is needed for a functional chromodomain Y-linked gene, consider instead CDY1 or CDY2A, which are protein-coding[3][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromodomain Y-linked 3 pseudogene (CDY3P).